chr4-1024483-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001004356.3(FGFRL1):āc.891T>Cā(p.Asp297Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0394 in 1,612,472 control chromosomes in the GnomAD database, including 1,546 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.034 ( 135 hom., cov: 33)
Exomes š: 0.040 ( 1411 hom. )
Consequence
FGFRL1
NM_001004356.3 synonymous
NM_001004356.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.84
Genes affected
FGFRL1 (HGNC:3693): (fibroblast growth factor receptor like 1) The protein encoded by this gene is a member of the fibroblast growth factor receptor (FGFR) family, where amino acid sequence is highly conserved between members and throughout evolution. FGFR family members differ from one another in their ligand affinities and tissue distribution. A full-length representative protein would consist of an extracellular region, composed of three immunoglobulin-like domains, a single hydrophobic membrane-spanning segment and a cytoplasmic tyrosine kinase domain. The extracellular portion of the protein interacts with fibroblast growth factors, setting in motion a cascade of downstream signals, ultimately influencing mitogenesis and differentiation. A marked difference between this gene product and the other family members is its lack of a cytoplasmic tyrosine kinase domain. The result is a transmembrane receptor that could interact with other family members and potentially inhibit signaling. Multiple alternatively spliced transcript variants encoding the same isoform have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 4-1024483-T-C is Benign according to our data. Variant chr4-1024483-T-C is described in ClinVar as [Benign]. Clinvar id is 1170810.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.85 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.109 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FGFRL1 | NM_001004356.3 | c.891T>C | p.Asp297Asp | synonymous_variant | 6/7 | ENST00000510644.6 | NP_001004356.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FGFRL1 | ENST00000510644.6 | c.891T>C | p.Asp297Asp | synonymous_variant | 6/7 | 1 | NM_001004356.3 | ENSP00000425025.1 | ||
FGFRL1 | ENST00000264748.6 | c.891T>C | p.Asp297Asp | synonymous_variant | 5/6 | 1 | ENSP00000264748.6 | |||
FGFRL1 | ENST00000504138.5 | c.891T>C | p.Asp297Asp | synonymous_variant | 6/7 | 1 | ENSP00000423091.1 | |||
FGFRL1 | ENST00000398484.6 | c.891T>C | p.Asp297Asp | synonymous_variant | 7/8 | 5 | ENSP00000381498.2 |
Frequencies
GnomAD3 genomes AF: 0.0339 AC: 5162AN: 152106Hom.: 132 Cov.: 33
GnomAD3 genomes
AF:
AC:
5162
AN:
152106
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0389 AC: 9614AN: 246846Hom.: 286 AF XY: 0.0379 AC XY: 5097AN XY: 134334
GnomAD3 exomes
AF:
AC:
9614
AN:
246846
Hom.:
AF XY:
AC XY:
5097
AN XY:
134334
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0400 AC: 58417AN: 1460248Hom.: 1411 Cov.: 33 AF XY: 0.0394 AC XY: 28631AN XY: 726442
GnomAD4 exome
AF:
AC:
58417
AN:
1460248
Hom.:
Cov.:
33
AF XY:
AC XY:
28631
AN XY:
726442
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0340 AC: 5179AN: 152224Hom.: 135 Cov.: 33 AF XY: 0.0343 AC XY: 2553AN XY: 74414
GnomAD4 genome
AF:
AC:
5179
AN:
152224
Hom.:
Cov.:
33
AF XY:
AC XY:
2553
AN XY:
74414
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
275
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
FGFRL1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 23, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at